G1 Therapeutics shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.
G1 Therapeutics shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.
G1治療公司股價上漲,此前該公司公佈了好於預期的第四季度每股收益和銷售業績。
G1 Therapeutics shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.
G1治療公司股價上漲,此前該公司公佈了好於預期的第四季度每股收益和銷售業績。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。